Tokyo, March 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060789) titled 'Differences in Prognosis Based on Timing of Anti-VEGF Therapy loading dose in Retinal Vein Occlusion: A Multicenter, Retrospective, Observational Study' on March 31.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Medical University Ibaraki Medical Center
Condition:
Condition - Retinal Vein Occlusion
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to establish a multicenter retrospective clinical registry for cases initiating anti-VEGF therapy for macular edema associated with retinal vein occlusion. Using this database, we aim to analyze and evaluate, based on medical records, the impact of the presence or absence of a loading dose on treatment outcomes one year after initiation, thereby contributing to the optimization of RVO treatment in Japan.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients with retinal vein occlusion (RVO)
2) RVO cases seen since 2020
3) Cases followed for one year
4) Cases aged 20 years or older
Key exclusion criteria - 1) Cases under 20 years of age
2) Cases already treated with anti-VEGF agents, laser therapy, or surgery
3) Patients deemed unsuitable as research subjects by the principal investigator or co-investigator
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 28 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069551
Disclaimer: Curated by HT Syndication.
